Minutes - TRIPS Council - View details of the intervention/statement

H.E. Ambassador Dagfinn Sørli (Norway)
13; 14 PROPOSAL FOR A WAIVER FROM CERTAIN PROVISIONS OF THE TRIPS AGREEMENT FOR THE PREVENTION, CONTAINMENT AND TREATMENT OF COVID-19; DRAFT GENERAL COUNCIL DECLARATION ON THE TRIPS AGREEMENT AND PUBLIC HEALTH IN THE CIRCUMSTANCES OF A PANDEMIC

401.   The most solemn obligation of every government is to protect the life and health of its people. The threatened scale of the COVID-19 pandemic became evident in early 2020. Dr Tedros Adhanom Ghebreyesus, Director-General of the WHO, declared the situation a Public Health Emergency of International Concern on 30 January 2020. The need for scaled-up access to diagnostics, treatments, vaccines and personal protective equipment was manifest. 402.   The co-sponsors approached Members of the World Trade Organization with a straightforward request. Namely, that international obligations regarding the protection of intellectual property rights under the TRIPS Agreement be waived temporarily during the pandemic. This straightforward request was made so that countries at all levels of economic and social development, with diverse public health systems, and with different approaches to addressing the pandemic, could move forward by taking appropriate measures without the potential threat of trade disputes and sanctions regarding intellectual property impairing them. There was good reason to believe that health products would be in global short supply. This circumstance was most likely to persist for some time. New products required clinical testing and approval. New production facilities needed to be brought online and certified. Supply chains needed to be integrated. The clock began ticking early in 2020. 403.   Middle- and low-income countries had reason to be concerned. Much of the latest technology used to develop and manufacture necessary health products was owned and controlled by companies, governments and other institutions based in high-income countries. Without access to this technology, the road to manufacturing and distributing health products would be restricted. Access to health products would be at the discretion of a relative handful of high-income country technology owners. As the COVID-19 pandemic continues to rage on globally, there have been over 259 million confirmed cases of COVID-19, including over 5 million deaths, reported to WHO. As we know, this is a gross undercount if we take into consideration excess deaths. As of 25 November 2021, a total of just over 7.7 million vaccine doses have been administered.27 404.   Almost half of the vaccines sold by AstraZeneca, Pfizer/BioNTech, Moderna, and Johnson and Johnson have been delivered to high-income countries, even though such countries only comprise 16% of the world's population. The countries of the African Union (AU) collectively have a population that is three times larger than the countries of the European Union. Yet the African Union Vaccine Acquisition Trust, a vaccine procurement platform, has only been able to purchase 100 million doses from Pfizer/BioNTech and Johnson and Johnson. By contrast, the EU has been able to purchase nearly 1.5 billion doses from AstraZeneca, Pfizer/BioNTech, Moderna, and Johnson and Johnson, or approximately 15 times the number of doses compared to the AU. 405.   Through world class genomic sequencing and epidemiology, South African scientists were able to detect the Omicron variant. Scientists have also identified cases in Hong Kong, China; Australia; Belgium; Italy; the United Kingdom; Germany; Austria; Denmark; and Israel; and it is now spreading to other countries as well. Due to high standards of transparency and in the spirit of solidarity, South African authorities made the detection of the variant known. In response, South Africa and neighbouring countries have been subjected to unscientific, knee jerk travel bans. Predictably, countries opposing the waiver are at the forefront of implementing such measures. It is important to note that unless vaccines are universally available, mutations are most likely to be the outcome, putting everyone at risk, even countries that have achieved high vaccination rates. We call for solidarity and constructive engagement in the TRIPS Council to approve the waiver rather than discriminatory bans that lock Africa away. 406.   The Committee on Economic, Social and Cultural Rights (CESCR) has highlighted that "the current restrictions imposed by the intellectual property rules in the TRIPS Agreement make it very difficult" to achieve the international cooperation needed for the massive scale up required to ensure universal access to diagnostics, medications, vaccines, therapeutics and other relevant health products to prevent, treat and control COVID-19. This does not have to be a developed versus developing country debate. As United States President Biden said on 26 November 2021, "[t]he news about this new variant should make clearer than ever why this pandemic will not end until we have global vaccinations", and reiterates the importance of waiving IP protections. For months the International Monetary Fund and the World Bank have been warning that an end to the pandemic requires poor people as well as rich to be vaccinated. 407.   The lack of a multilateral solution to approve the targeted and time-bound TRIPS waiver that would result in diversification of production, as we have repeatedly warned, is creating a fertile breeding ground for the emergence of new variants. We have always said that no one is safe until everyone is safe. The world has been waiting for over a year for a resolution. However it is clear that the lack of a decision shows that multilateralism has failed the test. If ever there was a time for some international solidarity this was it. We have always said that this is not an ideological debate. We believe it is possible to find a balanced outcome that preserves the incentives for research and innovation and that responds to the public health crisis that we face. The proposal recognizes that we are in an unprecedented crisis and it calls for concomitant exceptional measures to be taken to save lives and to take us on a path of sustainable economic recovery. The stop-start we currently have is hurting developing countries the most as they cannot cushion their economies. They just do not have the fiscal space to do so. 408.   Importantly, we do not need a Ministerial Conference to take decisions that save people's lives. That is why we called for a decision in the July 2021 General Council. The General Council has always approved waivers and can take a decision on important matters such as this. The postponement of MC12 due to the Omicron variant emphasizes the need for engaging in a solutionoriented and truly text-based discussion. When will the TRIPS Council engage in a textbased negotiation process? If not now, when? We have engaged in a solution-oriented discussion with various Members in the last few weeks and indicated readiness to show flexibility that makes a real difference on the ground. We have shared our thoughts on a landing zone that can take us forward. We have always said that we need to move beyond the binary of the two proposals. It is unfortunate that even this flexibility has not assisted to move us forward. 409.   While the first duty of any government is to ensure the safety of its own people, there are times when this can only be done by acting collectively. This is one of them. Some problems are global in nature. Voluntary arrangements and donations, while helpful, have not been sufficient to result in equitable distribution. In reality, we have seen that voluntary licences contain restrictive terms and conditions, such as restrictive coverage that excludes supply to many developing countries, which contributes greatly to inequitable access. This is why we continue to call for transparency of contracts. In addition, waiver opponents said that COVAX would deliver equitable access. However as we approach the end of 2021, COVAX has only delivered about 500 million vaccines, approximately 25% of what it was expected to deliver in 2021. Notably COVAX has cut its vaccine delivery forecasts by 25% (from 2 billion doses to 1.5 billion doses). 410.   Failure to agree on a multilateral outcome to address IP barriers, coupled with the imposition of restrictions that run contrary to the advice and guidance by the World Health Organization cast a dim light on the ability of this institution to act in solidarity during an international emergency, as recognized by the WHO. The arguments in favour of waiving intellectual property rights have become even more urgent than when we submitted the proposal in October 2020. We call on Members that are yet co-sponsors to join us. 411.   According to the IMF Chief, Kristalina Georgieva, the most serious obstacle to full recovery remains the COVID-19 vaccine divide between rich and poor states. According to the IMF Chief, "[w]e face a global recovery that remains hobbled by the pandemic and its impact." She further stated that "[w]e are unable to walk forward properly – it is like walking with stones in our shoes". The very credibility of this institution will be determined by the outcomes reached in the TRIPS Council. To this end, the WTO needs to prioritize urgent textbased negotiations on a TRIPS waiver. This must take precedence over any other negotiations. The suspension of MC12 offers us an opportunity to refocus all our efforts on reaching a mutually acceptable outcome to the TRIPS Waiver Proposal. We need to engage in text-based negotiations and convene a special session of the General Council as soon as possible to bring the waiver into effect. We have the time and the platform to work purposefully to achieve an outcome that can reestablish our relevance to the world looking on. The only question is do we have the will?

78. The Chair said that the "Proposal for A Waiver from Certain Provisions of The TRIPS Agreement for the Prevention, Containment and Treatment of COVID-19" had been circulated in document at the request of India and South Africa on 2 October 2020. It had since been co- sponsored by the delegations of the Plurinational State of Bolivia; Kenya; Eswatini; Mozambique; Pakistan; the Bolivarian Republic of Venezuela; Mongolia; Zimbabwe; Egypt; the African Group; the LDC Group; the Maldives; Fiji; Namibia; Vanuatu; Indonesia and Jordan. A revised proposal had been circulated by the co-sponsors on 21 May 2021 in document , which had since been co-sponsored by the delegation of Malaysia.
79. He recalled that, since the formal meeting of the TRIPS Council on 8-9 June 2021, there had been an intensive schedule of dedicated meetings to discuss this and related proposals in various formats. This involved a series of small-group consultations with delegations and group coordinators, five informal open-ended meetings for the purposes of transparency and inclusiveness, and two additional formal meetings of the Council to adopt successive status reports to the General Council. In its most recent oral status report to the General Council on 4 October, Members had concluded that: "[…] the TRIPS Council has not yet completed its consideration of the revised waiver request. The TRIPS Council will therefore continue its consideration of the revised waiver request, including through small-group consultations and informal open-ended meetings, and report back to the General Council as stipulated in Article IX:3 of the Marrakesh Agreement. In addition, the TRIPS Council will also continue in the same manner its consideration of the other related proposals by Members".
80. At the informal open-ended meeting of the Council on 14 September 2021, delegations had expressed their willingness to continue discussing specific aspects of the proposals in small-group meetings. He had therefore suggested to hold one small-group meeting in each of the next two weeks, and then reunite for an informal open-ended meeting of the TRIPS Council for the sake of openness, transparency, and inclusiveness, and to provide an opportunity to take stock and discuss how to advance further in light of that experience.
81. The Chair informed the Council that the two small-group consultations were held on 23 and 29 September. At the first meeting, which was dedicated to discussing 'scope' and 'implementation', delegations had engaged constructively in the questions underlying the waiver proposal and discussed the practical differences between TRIPS flexibilities and the waiver approach at the national level. On that occasion he had also heard delegations expressing their willingness to explore areas of common interest. One particular aspect of the discussion had touched on the existing TRIPS flexibilities and the concern voiced by the co-sponsors of the revised waiver proposal, that the use of such flexibilities was cumbersome. Thus, the second small-group consultation had aimed to examine one of the TRIPS flexibilities cited in the discussions, namely the requirements for using compulsory licensing in Articles 31, 31bis and the Annex of the TRIPS Agreement; and to relate any assessment of the practical impact of these requirements to the two proposals before the Council. Delegations had detailed exchanges on individual sub-paragraphs of Article 31 and 31bis of the TRIPS Agreement, and their impact on the practical use of compulsory licensing. In general, deliberations had taken place in a constructive atmosphere and it seemed that some of these detailed discussions could be pursued further. Some delegations had also voiced their frustration with the lack of progress, while a number of delegations had urged Members to focus on practical areas where consensus could be feasible in the short term.
82. At the informal open-ended meeting of 4 October 2021, the co-sponsors of the revised waiver proposal had once again indicated their flexibility towards considering the proposal by the European Union as a complementary approach, but they had emphasized that, in their view, a TRIPS waiver was a central and necessary element in the WTO's response to the pandemic. They had urged Members to end the binary view of the two proposals as alternatives.
83. Other Members, while welcoming the increased engagement in the small-group consultations, had remained unconvinced that a waiver would be an appropriate or effective tool to scale up production or ensure equitable distribution of vaccine doses around the world. These delegations had highlighted the broader Trade and Health initiative as the right tool to address the supply chain bottlenecks that the pandemic response was facing. Some had urged convergence on the basis of the proposal by the European Union aimed at clarifying, or improving the functioning of, existing TRIPS flexibilities.
84. While it had been clear that discussions had not bridged the persisting disagreement on the fundamental approaches underlying the different proposals, he noted that all delegations remained willing to continue discussion on the proposals in the various meeting formats.
85. The Chair stressed the importance of bilateral engagement between delegations in order to explore common ground and find possible landing zones, which Members could agree upon to conclude these discussions in the TRIPS Council. He said the world was expecting the Council to find a resolution of these discussions soon, and this could only happen if delegations could find agreement amongst themselves. He encouraged delegations to intensify their bilateral contacts and indicated his availability to facilitate engagement in a smaller group, keeping in mind that any outcomes from engagement between individual Members regarding the conclusion of the discussions should feed back into the Council and through it into the broader MC12 discussions. He sincerely hoped that engagement between delegations could still lead to something the Council could agree on, be that in the shape of a recommendation of the TRIPS Council as foreseen under Article IX:3 of the Marrakesh Agreement, or be it through some other consensus decision representing a conclusion of this process.
86. The representatives of the United Kingdom; South Africa; Pakistan; Bangladesh; the Plurinational State of Bolivia; Chile; Cuba; Nigeria, the Bolivarian Republic of Venezuela; Egypt; Indonesia; the Kingdom of Saudi Arabia; India; the European Union; Korea; Singapore; Türkiye; Japan; China; Switzerland; Norway; New Zealand; the United States; Namibia; Colombia; Australia; Brazil; and Mozambique took the floor.
87. The Chair said that, with respect to the suggestion to move the current TRIPS discussion into the process on trade and health issues Ambassador Walker was facilitating under the aegis of the Chair of the General Council at this time, it seemed clear to him that any conclusions on how different WTO disciplines should respond to the pandemic would all have to be part of the MC12 outcome document, and that IP was clearly expected to be part of that, in some form or other. Considering the attention and bandwidth that the Council's discussion had occupied over the last year, he was not concerned that the waiver request would somehow be forgotten in any prospective MC12 ministerial declaration.
88. In terms of procedure, he said it was for Members to decide whether they would want to terminate the waiver discussions in the TRIPS Council at that time to continue them in Ambassador Walker's process together with the equally complex trade-related considerations discussed there, or whether they would prefer to continue focused efforts to find a consensus conclusion on the IP-related discussions in the TRIPS context, which could then be introduced into an overall MC12 outcome document, together with any outcome resulting from Ambassador Walker's process.
89. While procedural considerations should not stand in the way if consensus among Members emerges, the Chair recalled that it was the TRIPS Council's obligation to come up with a recommendation, so that the procedure foreseen under the waiver provisions of the Marrakech Agreement could be properly concluded.
90. In light of the discussion, it seemed that the Council was not yet ready to agree on a recommendation, but that there remained a willingness to continue discussions and exploring possible common ground. The Chair proposed to keep the agenda item open, and thus permit delegations to further explore common ground and possible compromise solutions to this discussion. If there emerged an indication that Members were in a position to reach consensus, he would reconvene the Council to see whether an agreement could be reached on how to conclude these discussions before the Ministerial Conference, in a timely manner.
91. The Council took note of the statements made and agreed to keep the agenda item open.
92. During the reconvened meeting on 18 November, the Chair recalled that, as discussed at an informal open-ended meeting on 15 November, he had circulated draft language for an oral status report to the General Council on the same day in document JOB/IP/53, with an invitation to Members to comment by 16 November 2021. An agenda item for this status report had also been placed on the agenda of the General Council meeting scheduled for 22-23 November in the usual fashion. Since no comments had been received on the draft language, delegations had been informed on 17 November that the Chair would propose the text as circulated for adoption on 18 November. The language for the oral status report to the General Council which had been circulated in document JOB/IP/53 read as follows:
"At the meeting of the TRIPS Council on 15-16 October 2020, India and South Africa introduced document , requesting a waiver from certain provisions of the TRIPS Agreement for the prevention, containment and treatment of COVID-19, which had been circulated on 2 October 2020 and has since been co-sponsored by the delegations of Kenya, Eswatini, Mozambique, Pakistan, the Plurinational State of Bolivia; Bolivarian Republic of Venezuela; Mongolia; Zimbabwe; Egypt; the African Group; the LDC Group; the Maldives; Fiji; Namibia; Vanuatu; Indonesia and Jordan.
Since the introduction of the document, discussions took place in various formal and informal TRIPS Council meetings. Delegations exchanged views, asked questions, sought clarifications and provided replies, clarifications, and information, including through documents , , , and , on the waiver request.
On 21 May 2021 the co-sponsors issued a revised proposal which was circulated in document . The revised waiver request was presented at an informal open-ended meeting of the Council on 31 May, and introduced at its formal meeting on 8-9 June 2021. It has since been co-sponsored by Malaysia. On 29 September 2021, the co-sponsors circulated a summary of their interventions in document .
Since the last oral status report delivered on 7 October 2021, discussions continued in small-group consultations, at a formal meeting of 13-14 October, at informal open-ended meetings on 5 and 15 November, and at an informal and resumed formal meeting on 18 November 2021.
In the course of discussions on the revised waiver proposal, delegations held focused discussions on the topics of 'scope', both from the perspective of products and of IP rights, on 'duration', 'implementation' and on protection of undisclosed information. Delegations engaged positively and their detailed substantive exchanges helped clarify various aspects and nuances of positions. While delegations remain committed to the common goal of providing timely and secure access to high-quality, safe, efficacious and affordable vaccines and medicines for all, disagreement persists on the fundamental question of whether a waiver is the appropriate and most effective way to address the shortage and inequitable distribution of and access to vaccines and other COVID-19 related products.
In addition, a proposal for a draft General Council declaration on the TRIPS Agreement and Public Health in the circumstances of a pandemic, issued by the European Union and circulated in document , has also been discussed in meetings since its circulation on 21 June 2021. Delegations exchanged views, asked questions, sought clarifications and provided replies, clarifications, and information. Disagreement persists on the fundamental question of whether this proposal is the appropriate and most effective way to address the shortage and inequitable distribution of and access to vaccines and other COVID-19 related products.
This means that the TRIPS Council has not yet completed its consideration of the revised waiver request. The TRIPS Council will therefore continue its consideration of the revised waiver request, including through small-group consultations and informal open-ended meetings, and report back to the 12th Ministerial Conference as stipulated in Article IX:3 of the Marrakesh Agreement.
In addition, the TRIPS Council will also continue in the same manner its consideration of the other related proposals by Members."
93. The Chair proposed that the Council formally adopt the status report as a factual reflection of discussions on the TRIPS Waiver request.
94. The Council so agreed.
95. The Chair thanked delegations for their cooperation. He would deliver this report to the General Council, on 22-23 November, as agreed.
96. The representatives of India; the European Union; South Africa; Indonesia; Switzerland; the United Kingdom; and the United States took the floor.
97. The Chair said that, in line with the report that had been adopted, it was therefore understood that the agenda items 13 and 14 on the Council's agenda continued to remain open in order to permit more time for bilateral engagement, with a view to resuming – at short notice if necessary – the meeting, when there were indications that Members might be ready to reach an agreement.
98. For the next resumption of the Council's meeting, meeting room facilities were available for a formal resumption for Monday, 29 November 2021. This did not exclude the possibility of an earlier resumption at short notice should the circumstances require this.
99. The Chair encouraged delegations to remain seriously engaged, flexible and focused on an outcome, which remained within reach. The role of IP in the context of the pandemic had become the centre of attention in the run-up to this Ministerial Conference and a pragmatic and tangible outcome of these discussions would be a strong and positive signal to the Ministerial Conference and the global community as a whole. He would reach out to delegations to ensure that every opportunity to find possible landing zones ahead of MC12 would be used.
100. The Council took note of the statements made.
101. At the reconvened meeting on 29 November, the Chair suggested to take up agenda items 13 and 14 together, as most delegations were making one single statement covering both agenda items. He recalled that at the resumed meeting on 18 November, the Council had adopted an oral status report to the General Council, which he had delivered on 22 November 2021. This report had concluded that "the TRIPS Council will therefore continue its consideration of the revised waiver request, including through small-group consultations and informal open-ended meetings, and report back to the 12th Ministerial Conference as stipulated in Article IX:3 of the Marrakesh Agreement. In addition, the TRIPS Council will also continue in the same manner its consideration of the other related proposals by Members."
102. Since then, the Chair had held consultations with individual and groups of delegations, as well as a small-group consultation on 25 November. He had also circulated a draft report to the Ministerial Conference in document JOB/IP/54. However, in light of the indefinite postponement of the 12th Ministerial Conference, announced on 26 November 2021, the draft report was no longer proposed for adoption.
103. At the informal meeting that had preceded the this reconvened formal meeting, delegations had exchanged views on whether and how they wished to approach work on these items. He had shared his view that, although the much-awaited ministerial engagement on the important question of the role of IP in the pandemic had now been delayed, the Council could not afford to lose the momentum that had been gathering in the discussions among delegations during the previous week. From delegations' interventions in that meeting it was his sense that there was unanimous support for keeping the momentum of the discussions and continuing to engage on these matters, to try and harvest any outcome that may still be possible under the changed circumstances.
104. The representatives of South Africa; the European Union; India; the United Kingdom; Vanuatu; Indonesia; Chad, on behalf of the LDC Group; the Plurinational State of Bolivia; Pakistan; Brazil; Maldives; Switzerland; and Tanzania, on behalf of the African Group, took the floor.
105. The Chair said that he would consult with delegations to help facilitate continued engagement, and with a view to finding consensus on a substantive solution. He suggested that the agenda items remain open, with a view to resuming the meeting, at short notice, if necessary, when there are indications that Members might be closer to agreement on how to conclude these items. He noted that the next options for reconvening the Council's meeting were 10 and 16 December.
106. The Council so agreed.
107. The Chair thanked delegations for their engagement on this complex and highly politicized issue. He knew that all delegations shared the common goal of providing timely and secure access to high-quality, safe, efficacious and affordable vaccines and medicines for all, and all were working hard to narrow their differences on how this common goal could be achieved. He said he had heard the shared view that IP should not be a barrier to access to medicines, and that governments should be able to permit manufacturers that were able and ready to produce COVID-19 vaccines to start producing without worrying about a patent.
108. While the Chair regretted that the Council had not been able to reach consensus on a substantive recommendation to the 12th Ministerial Conference the previous week, he remained convinced that a pragmatic compromise solution was within reach, if the political will could be mustered. Although the Council must now continue its work without the political input from ministers, he recalled that a practical, tangible WTO response to the pandemic was needed, now more than ever. As the pandemic continued to challenge the world's sense of stability, it was important that the WTO reached agreement on meaningful responses to these challenges. He urged delegations to remain fully engaged with a sense of urgency, and with the objective to find a pragmatic consensus-based outcome. This is not the moment to let up, but rather – to quote Lord Tennyson – "to strive, to seek, to find, and not to yield."
109. At the reconvened meeting on 16 December, the Chair suggested to once again take up agenda items 13 and 14 together, as most delegations were making one single statement covering both agenda items. He reported that he had held consultations with a group of co-sponsors, and with a group of 'non-proponents', respectively, on 8 and 14 December. These separate meetings had not indicated any further engagement between these groups at delegation level since mid-November, nor had they revealed any movement in positions. The co-sponsors had re-iterated their calls for the urgent commencement of text-based negotiations on the basis of the revised waiver proposal document , while other delegations had seen no promise in any textual engagement as long as fundamental disagreements persisted on the merits of different approaches.
110. The Chair also indicated he had kept in touch with the Director General and DDG Gonzales with regard to their political contacts with Members. He invited delegations to share their views on recent developments and on next steps the Council should take in these matters.
111. The representatives of Argentina; South Africa; Mozambique; the European Union; Colombia; Pakistan; Brazil; Australia; Tanzania, on behalf of the African Group; the Plurinational State of Bolivia; Nigeria; China; the United States; New Zealand; Norway; Switzerland; Indonesia; India; and the United Kingdom took the floor.
112. The Chair said that what he had heard confirmed the impression he had gathered in the consultations with the two groups he had described earlier. On the one hand, there was the co- sponsors' insistence that textual engagement should be commenced based on the entirety of their proposal. On the other hand, there remained significant scepticism and outright opposition vis- à-vis the waiver approach among a number of delegations, who were therefore reluctant to engage on the basis of a text with whose underlying premise they disagree.
113. He recalled that, during the first small-group consultations in June, the text of the revised waiver had, in fact, been put on the screen with a view to discussing it – but the differences described above, and a certain lack of trust among delegations, meant that serious line-by-line engagement on that text had simply not been possible among delegations. Despite this, delegations had managed to have quite a number of meetings on substance and on additional proposals – and this was reflected in the reports to the General Council.
114. During the summer, the Chair said, it had been very much hoped that bilateral engagements among delegations would overcome these obstacles and lead to a situation where constructive engagement in the Council could be based on a pragmatic focus on common ground, but despite some encouraging signs along the way, this had ultimately not been the case. It was his impression, that these obstacles unfortunately still remained in place, and he was not able to detect any convergence towards a common ground for textual engagement that was any more promising than what had been attempted earlier in the year. To be precise, he said, he did not mean agreement on a text, but on a basis for engagement.
115. He said that, in the last few weeks leading up to the planned ministerial conference, it had been clear that Members were preparing for engagement at the political level at the conference. While it had been rightly pointed that the waiver was not formally part of the designated outcome of MC12 and could be addressed at the level of the TRIPS Council and the General Council, it had been clear to everybody, given the timing, that Members wanted those issues to be discussed at the conference. This was also reflected in the draft report that the Council was ready to adopt at the meeting on 29 November. In light of the postponement of MC12, Members had instead expressed their willingness and intention to intensify their engagement with each other. The TRIPS Council therefore had decided to stay in session, meaning that the Council could be reconvened at short notice.
116. The Chair said that, in the Heads of Delegations meeting held on 2 December he had shared with Members his personal assessment that another type of engagement was needed between members than what had been witnessed for some time. His first suggestion had been that delegations should focus more on what united them than on what divided them, referring also to the common objectives shared by Members.
117. His second suggestion had been that political engagement and input was needed to be able to change the current dynamic, input that had been anticipated from the ministerial conference. He had therefore urged members, in particular those who have taken a leading role in the discussions on these matters, to engage with each other, across the aisle, with a sense of urgency, not only here in Geneva, but also, and most importantly, at the political level. He was therefore encouraged by what he had heard from some members regarding such political engagement taking place now.
118. Against this background, the Chair believed that the best course of action for the immediate future was to let the on-going high-level engagement continue and mature. If a common approach to the discussions on these items could be developed among these Members, he said, this could hopefully contribute to unlocking the situation in the Council and allow all Members to take a step forward towards developing a consensus outcome. He had also taken note of Members underlining the need for transparency and inclusiveness, while welcoming engagement among a few Members. He said that it went without saying that any achievement among a small group of Members would have to be brought to the larger membership. He reiterated his belief that a practical, tangible WTO response to the pandemic is needed, now more than ever. If members focus on that, he also believed it was within reach.
119. In light of this, the Chair proposed that the Council once again keep the agenda items open, with a view to resuming the meeting – at short notice, if necessary – when there are indications that Members might be closer to a common understanding on how to proceed towards a possible landing zone and ultimately a consensus-based solution. In the meantime, he would remain in touch with delegations to keep abreast of any developments and would make practical arrangements to be able to resume whenever there were any new developments or a need to inform Members of the current state of play.
120. The Council so agreed.
121. At the reconvened meeting on 22 February 2022, the Chair suggested to once again take up agenda items 13 and 14 together, as had been the case in past meetings. The Chair recalled that, as indicated in his communication dated 11 February 2022, he had circulated draft language for an oral status report to the General Council in document JOB/IP/55 on 16 February 2022, with an invitation to Members to comment by 18 February 2022. An agenda item for this status report had also been placed on the agenda of the General Council meeting scheduled for 23-24 February in the usual fashion. Since no comments had been received on the draft language, delegations had been informed that the Chair would propose the text as circulated for adoption on 22 February 2022. The language for the oral status report to the General Council which had been circulated in document JOB/IP/55 read as follows:
At the meeting of the TRIPS Council on 15-16 October 2020, India and South Africa introduced document , requesting a waiver from certain provisions of the TRIPS Agreement for the prevention, containment and treatment of COVID-19, which had been circulated on 2 October 2020 and has since been co-sponsored by the delegations of Kenya, Eswatini, Mozambique, Pakistan, Bolivia, Venezuela, Mongolia, Zimbabwe, Egypt, the African Group, the LDC Group, the Maldives, Fiji, Namibia, Vanuatu, Indonesia and Jordan.
Since the introduction of the document, discussions took place in various formal and informal TRIPS Council meetings. Delegations exchanged views, asked questions, sought clarifications and provided replies, clarifications, and information, including through documents , , , and , on the waiver request.
On 21 May 2021 the co-sponsors issued a revised proposal which was circulated in document . The revised waiver request was presented at an informal open-ended meeting of the Council on 31 May, and introduced at its formal meeting on 8-9 June 2021. It has since been co-sponsored by Malaysia and Argentina. On 29 September 2021, the co-sponsors circulated a summary of their interventions in document .
Status reports on the considerations by the TRIPS Council on the revised "Proposal for a Waiver from Certain Provisions of the TRIPS Agreement for the Prevention, Containment and Treatment of COVID-19" were delivered to the General Council on 34 March, 5-6 May, 27 July, 7 October and, most recently, on 22 November 2021.
In the course of discussions on the revised waiver proposal, delegations held focused discussions on the topics of 'scope', both from the perspective of products and of IP rights, on 'duration', 'implementation' and on protection of undisclosed information. Delegations engaged positively and their detailed substantive exchanges helped clarify various aspects and nuances of positions. While delegations remain committed to the common goal of providing timely and secure access to high quality, safe, efficacious and affordable vaccines and medicines for all, disagreement persists on the fundamental question of whether a waiver is the appropriate and most effective way to address the shortage and inequitable distribution of and access to vaccines and other COVID related products.
In addition, a proposal for a draft General Council declaration on the TRIPS Agreement and Public Health in the circumstances of a pandemic, issued by the European Union and circulated in document , has also been discussed in meetings since its circulation on 21 June 2021. Delegations exchanged views, asked questions, sought clarifications and provided replies, clarifications, and information. Disagreement persists on the fundamental question of whether this proposal is the appropriate and most effective way to address the shortage and inequitable distribution of and access to vaccines and other COVID-related products.
This means that the TRIPS Council has not yet completed its consideration of the revised waiver request. The TRIPS Council will therefore continue its consideration of the revised waiver request, and report back to the General Council as stipulated in Article IX:3 of the Marrakesh Agreement.
In addition, the TRIPS Council will also continue in the same manner its consideration of the other related proposals by Members.
122. The Chair proposed that the Council formally adopt the status report as a factual reflection of discussions on the TRIPS Waiver request.
123. The Council so agreed.
124. The Chair thanked delegations for their cooperation and said he would deliver this report to the General Council, on 23-24 February, as agreed. He recalled that, given the upcoming opportunities for delegations to place formal statements on the record at the General Council and at the next formal meeting of the TRIPS Council on 9-10 March, he was not intending to open the floor under this agenda item, and he thanked delegations for their cooperation in this regard.
125. The Secretariat briefly announced that a Secretariat Briefing on the TRIPS Council intended for new delegations would be held on 1 March 2022.
126. At the reconvened meeting of 18 November, the report to the General Council was adopted and the Chair said that, it was therefore understood that the agenda items 13 and 14 on the Council's agenda continued to remain open in order to permit more time for bilateral engagement, with a view to resuming – at short notice if necessary – the meeting, when there were indications that Members might be ready to reach an agreement. [see paragraphs 93-99]
127. At the reconvened meeting of 29 November, the Chair proposed to take agenda items 13 and 14 together, as delegations had been making a single statement. [see paragraphs 100-107]
128. At the reconvened meeting of 16 December, the Chair proposed to take agenda items 13 and 14 together, as delegations had been making a single statement. [see paragraphs 108-119]
IP/C/M/103, IP/C/M/103/Add.1, IP/C/M/103/Rev.1

27 https://covid19.who.int/